Trial Details
COMPLETEDBasic Information
| Clinical ID | c1581 |
|---|---|
| Identifier | NCT04254783 |
| Trial Title | A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC)|Crohn's Disease |
| Interventions | DRUG: Risankizumab|DRUG: Cytochrome P450 (CYP) Substrates |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Coronado |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2020-05-27 |
|---|---|
| Primary Completion Date | 2022-10-14 |
| Completion Date | 2022-10-14 |